Skip to Content

Nintedanib

In the US, Nintedanib (nintedanib systemic) is a member of the drug class multikinase inhibitors and is used to treat Chronic Fibrosing Interstitial Lung Disease With A Progressive Phenotype, Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XE31

CAS registry number (Chemical Abstracts Service)

0656247-17-5

Chemical Formula

C31-H33-N5-O4

Molecular Weight

540

Therapeutic Category

Antineoplastic agent: Tyrosine kinase inhibitor

Chemical Name

Methyl (3Z)-3-[({4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]phenyl}amino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate (WHO)

Foreign Names

  • Nintedanibum (Latin)
  • Nintedanib (German)
  • Nintedanib (French)
  • Nintedanib (Spanish)

Generic Names

Brand Names

  • Ofev
    Boeh.Ingel., Argentina; Boehringer Ingelheim, Denmark; Boehringer Ingelheim, Finland; Boehringer Ingelheim, Croatia (Hrvatska); Boehringer Ingelheim, Iceland; Boehringer Ingelheim, Lithuania; Boehringer Ingelheim, Latvia; Boehringer Ingelheim, Poland; Boehringer Ingelheim, Slovenia; Boehringer Ingelheim, Slovakia; Boehringer Ingelheim, Turkey; Boehringer Ingelheim España, Spain; Nippon Boehringer Ingelheim, Japan; Orifarm, Norway
  • Ofev 100 mg
    Boehringer Ingelheim, Hungary
  • Ofev 150 mg
    Boehringer Ingelheim, Hungary
  • Vargatef
    Boeh.Ingel., Argentina; Boehringer, Peru; Boehringer Ingelheim, Denmark; Boehringer Ingelheim, Croatia (Hrvatska); Boehringer Ingelheim, Lithuania; Boehringer Ingelheim, Poland; Boehringer Ingelheim, Slovenia; Boehringer Ingelheim España, Spain; Boehringer Ingelheim Pharma KG GmbH, Greece
  • Vargatef 100 mg
    Boehringer Ingelheim, Hungary
  • Vargatef 150 mg
    Boehringer Ingelheim, Hungary
  • Ofev
    Boehringer Ingelheim, Australia; Boehringer Ingelheim, Belgium; Boehringer Ingelheim, Canada; Boehringer Ingelheim, China; Boehringer Ingelheim, Czech Republic; Boehringer Ingelheim, Germany; Boehringer Ingelheim, Estonia; Boehringer Ingelheim, France; Boehringer Ingelheim, United Kingdom; Boehringer Ingelheim, Ireland; Boehringer Ingelheim, Netherlands; Boehringer Ingelheim, Norway; Boehringer Ingelheim, New Zealand; Boehringer Ingelheim, Romania; Boehringer Ingelheim, Sweden; Boehringer Ingelheim Pharma KG GmbH, Greece; Boehringer Ingelheim Pharmaceuticals, United States
  • Ofev 100mg
    Boehringer Ingelheim, Switzerland; Boehringer Ingelheim, Israel; Boehringer Ingelheim, Luxembourg; Boehringer Ingelheim International, Austria
  • Ofev 150mg
    Boehringer Ingelheim, Switzerland; Boehringer Ingelheim, Israel; Boehringer Ingelheim, Luxembourg; Boehringer Ingelheim International, Austria
  • Vargatef
    Boehringer Ingelheim, Belgium; Boehringer Ingelheim, Czech Republic; Boehringer Ingelheim, Estonia; Boehringer Ingelheim, United Kingdom; Boehringer Ingelheim, Ireland; Boehringer Ingelheim, Netherlands; Boehringer Ingelheim, Norway; Boehringer Ingelheim, Romania; Boehringer Ingelheim, Sweden; Boehringer Ingelheim, Slovakia
  • Vargatef 100mg
    Boehringer Ingelheim, Germany; Boehringer Ingelheim International, Austria; Boehringer Ingelheim International, Luxembourg
  • Vargatef 150mg
    Boehringer Ingelheim, Germany; Boehringer Ingelheim International, Austria; Boehringer Ingelheim International, Luxembourg

Glossary

TermDefinition
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.